Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helfand

Showing results (491-500 of 657) with videos related to

Pageof 66
Sort By:
Antimicrobial Agents and Chemotherapy|September 20, 2006
Role of Asp104 in the SHV beta-lactamaseChristopher R Bethel, Andrea M Hujer, Kristine M Hujer, et al.
The Prostate|August 18, 2025
Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility GenesChristian P Pavlovich, Jun Wei, Marta Gielzak, et al.
American Journal of Veterinary Research|July 15, 2000
Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinomaL E Fox, R C Rosenthal, R R King, et al.
The Journal of Urology|August 1, 2019
A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10David Cella, Abigail R Smith, James W Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trialD M Vail, E G MacEwen, I D Kurzman, et al.
The Prostate|May 1, 2019
Concept and benchmarks for assessing narrow-sense validity of genetic risk score valuesHongjie Yu, Zhuqing Shi, Yishuo Wu, et al.
The Journal of Surgical Research|June 12, 2017
Variation in readmission expenditures after high-risk surgeryBruce L Jacobs, Chang He, Benjamin Y Li, et al.
The Journal of Biological Chemistry|February 6, 2004
Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibitionDoritza Pagan-Rodriguez, Xiang Zhou, Reiko Simmons, et al.
British Journal of Cancer|August 25, 2020
Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK BiobankJun Wei, Zhuqing Shi, Rong Na, et al.
European Urology|January 7, 2023
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and PreventionTyler M Seibert, Isla P Garraway, Anna Plym, et al.
Pageof 66

Showing results (491-500 of 657) with videos related to

Sort By:
Pageof 66
Antimicrobial Agents and Chemotherapy|September 20, 2006
Role of Asp104 in the SHV beta-lactamaseChristopher R Bethel, Andrea M Hujer, Kristine M Hujer, et al.
The Prostate|August 18, 2025
Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility GenesChristian P Pavlovich, Jun Wei, Marta Gielzak, et al.
American Journal of Veterinary Research|July 15, 2000
Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinomaL E Fox, R C Rosenthal, R R King, et al.
The Journal of Urology|August 1, 2019
A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10David Cella, Abigail R Smith, James W Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trialD M Vail, E G MacEwen, I D Kurzman, et al.
The Prostate|May 1, 2019
Concept and benchmarks for assessing narrow-sense validity of genetic risk score valuesHongjie Yu, Zhuqing Shi, Yishuo Wu, et al.
The Journal of Surgical Research|June 12, 2017
Variation in readmission expenditures after high-risk surgeryBruce L Jacobs, Chang He, Benjamin Y Li, et al.
The Journal of Biological Chemistry|February 6, 2004
Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibitionDoritza Pagan-Rodriguez, Xiang Zhou, Reiko Simmons, et al.
British Journal of Cancer|August 25, 2020
Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK BiobankJun Wei, Zhuqing Shi, Rong Na, et al.
European Urology|January 7, 2023
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and PreventionTyler M Seibert, Isla P Garraway, Anna Plym, et al.
Pageof 66